Examine the impact of the TyG index on all-cause mortality and adverse cardiovascular events during hospitalization in critically ill patients.

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500101165

Enrollment

Unknown

Registered

2025-04-21

Start date

2023-06-30

Completion date

Unknown

Last updated

2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular and cerebrovascular diseases

Interventions

Low TYG group:None

Middle TYG group:None

High TYG group:None

Extremely high TYG group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age older than 18 years old, gender is not limited; 2. The patient has signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participated in other clinical trials within 3 months of this study; 2. Unable to cooperate with this study for any reason; 3. The researchers believe that it is not appropriate to include this trial.

Design outcomes

Primary

Measure	Time frame
TyG;	—

Secondary

Measure	Time frame
Cerebral infarction;Myocardial infarction;New heart failure;	—

Countries

China

Contacts

Public ContactPei Zhang

Intensive Care Unit of Department of Anesthesiology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

zhangpei1984pplive@126.com+86 158 3213 9133

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026